Literature DB >> 17420940

Protective effect of soy isoflavones and activity levels of plasma paraoxonase and arylesterase in the experimental nonalcoholic steatohepatitis model.

Bilal Ustundag1, Ibrahim Halil Bahcecioglu, Kazim Sahin, Sevda Duzgun, Suleyman Koca, Funda Gulcu, Ibrahim Hanifi Ozercan.   

Abstract

Nonalcoholic steatohepatitis (NASH) is characterized by diffuse fatty infiltration in the liver and ballooning degeneration and inflammation in hepatocytes. We aimed to study the protective effect of soy isoflavones on experimental NASH and their effects on plasma paraoxanese and arylesterase levels in rats. Twenty-eight male rats were divided into four groups: Group 1 (n=7) received an isocaloric normal diet for 8 weeks, Group 2 (n=7) was fed an isocaloric basal diet plus oral soy isoflavone for 8 weeks (100 mg/kg in diet), Group 3 (n=7) received a special diet that was methionine and choline deficient (MCD) and rich in fat for 8 weeks, and Group 4 (n=7) was fed a special diet that was MCD and rich in fat plus oral soy isoflavone for 8 weeks (100 mg/kg in diet). Blood samples were collected to measure plasma malondialdehyde (MDA), paraoxanese, and arylesterase and biochemical parameters. Tissue samples were duly taken for histopathological examination and measurement of tissue MDA levels. Plasma MDA levels were higher in Group 3 than in Groups 1, 2, and 4 (P <0.01, P <0.05, and P <0.05 respectively). Liver tissue MDA levels were also significantly higher in Group 3 compared to Groups 1, 2, and 4 (P <0.001, P <0.001, and P <0.05 respectively). A significant decrease was found in the plasma and liver tissue MDA levels in Group 4 compared to Group 3 (P <0.05 and P <0.05, respectively). The activity levels of plasma paraoxanase and arylesterase were significantly higher in Group 2 than in Groups 1 and 3 (P <0.05 and P <0.01, respectively). Also, the plasma paraoxanase and arylesterase levels were significantly higher in Group 4 compared to Groups 1 and 3 (P <0.05 and P <0.01, respectively). A significant reduction was observed in Group 4 in steatosis, inflammation, necrosis, and fibrosis compared to Group 3 (P <0.05 for each). We conclude that soy isoflavones seem to be effective in preventing liver damage by decreasing lipid peroxidation in the NASH model induced by a MCD diet. They stimulate and increase the activity of the antioxidative paraoxanase enyzme while decreasing the total cholesterol and triglyceride levels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17420940     DOI: 10.1007/s10620-006-9251-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  42 in total

1.  Plasma amino acids and the insulin/glucagon ratio as an explanation for the dietary protein modulation of atherosclerosis.

Authors:  A Sanchez; R W Hubbard
Journal:  Med Hypotheses       Date:  1991-09       Impact factor: 1.538

Review 2.  Soy protein and cardiovascular disease: the impact of bioactive components in soy.

Authors:  S M Potter
Journal:  Nutr Rev       Date:  1998-08       Impact factor: 7.110

Review 3.  Dietary proteins, cholesterol and thyroxine: a proposed mechanism.

Authors:  W A Forsythe
Journal:  J Nutr Sci Vitaminol (Tokyo)       Date:  1990-10       Impact factor: 2.000

4.  Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans.

Authors:  H Wiseman; J D O'Reilly; H Adlercreutz; A I Mallet; E A Bowey; I R Rowland; T A Sanders
Journal:  Am J Clin Nutr       Date:  2000-08       Impact factor: 7.045

5.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

Review 6.  Flavonoids protect LDL from oxidation and attenuate atherosclerosis.

Authors:  B Fuhrman; M Aviram
Journal:  Curr Opin Lipidol       Date:  2001-02       Impact factor: 4.776

7.  Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis.

Authors:  Jacob George; Natasha Pera; Nghi Phung; Isabelle Leclercq; Jing Yun Hou; Geoffrey Farrell
Journal:  J Hepatol       Date:  2003-11       Impact factor: 25.083

8.  Role of soy isoflavones in the hypotriglyceridemic effect of soy protein in the rat.

Authors:  Isabelle Demonty; Benoi;t Lamarche; Yves Deshaies; Hélène Jacques
Journal:  J Nutr Biochem       Date:  2002-11       Impact factor: 6.048

9.  Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia.

Authors:  Jerzy Bełtowski; Grazyna Wójcicka; Anna Jamroz
Journal:  Atherosclerosis       Date:  2003-09       Impact factor: 5.162

10.  Role of naringin supplement in regulation of lipid and ethanol metabolism in rats.

Authors:  Hyun-Ju Seo; Kyu-Shik Jeong; Mi-Kyung Lee; Yong Bok Park; Un Ju Jung; Hye-Jin Kim; Myung-Sook Choi
Journal:  Life Sci       Date:  2003-07-04       Impact factor: 5.037

View more
  23 in total

Review 1.  Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.

Authors:  Lucio G Costa; Gennaro Giordano; Clement E Furlong
Journal:  Biochem Pharmacol       Date:  2010-11-18       Impact factor: 5.858

Review 2.  Paraoxonases: metabolic role and pharmacological projection.

Authors:  Carlos Moya; Salvador Máñez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-02-06       Impact factor: 3.000

Review 3.  Novel insights into the mechanisms whereby isoflavones protect against fatty liver disease.

Authors:  Long-Xin Qiu; Tong Chen
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

4.  Genistein protects dermal fibrosis in bleomycin-induced experimental scleroderma.

Authors:  Süleyman Serdar Koca; Adile Ferda Dağlı; Servet Yolbaş; Nevzat Gözel; Ahmet Işık
Journal:  Eur J Rheumatol       Date:  2015-05-20

5.  The effect of radish sourced 4-(Methylthio)-3-butenyl isothiocyanate on ameliorating the severity of high fat diet inducted nonalcoholic fatty liver disease in rats.

Authors:  Hong You; Rui Hao; Ru Li; Liang Zhang; Yi Zhu; Yunbo Luo
Journal:  Int J Clin Exp Med       Date:  2015-09-15

6.  Altered distribution of regulatory lymphocytes by oral administration of soy-extracts exerts a hepatoprotective effect alleviating immune mediated liver injury, non-alcoholic steatohepatitis and insulin resistance.

Authors:  Tawfik Khoury; Ami Ben Ya'acov; Yehudit Shabat; Lidya Zolotarovya; Ram Snir; Yaron Ilan
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

Review 7.  Effects of Dietary Flavonoids on Reverse Cholesterol Transport, HDL Metabolism, and HDL Function.

Authors:  Courtney L Millar; Quinn Duclos; Christopher N Blesso
Journal:  Adv Nutr       Date:  2017-03-15       Impact factor: 8.701

8.  Naringenin is an inhibitor of human serum paraoxonase (PON1): an in vitro study.

Authors:  Abdolkarim Mahrooz; Mohammad-Reza Rashidi; Mohammad Nouri
Journal:  J Clin Lab Anal       Date:  2011-11       Impact factor: 2.352

9.  Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment.

Authors:  Judit Marsillach; Gerard Aragonès; Bharti Mackness; Michael Mackness; Anna Rull; Raúl Beltrán-Debón; Juan Pedro-Botet; Carlos Alonso-Villaverde; Jorge Joven; Jordi Camps
Journal:  Lipids Health Dis       Date:  2010-05-14       Impact factor: 3.876

10.  Paraoxonase-1 status in patients with hereditary hemochromatosis.

Authors:  Nicola Martinelli; Anabel García-Heredia; Helena Roca; Núria Aranda; Victoria Arija; Bharti Mackness; Michael Mackness; Fabiana Busti; Gerard Aragonès; Juan Pedro-Botet; Federica Pedica; Ivana Cataldo; Judit Marsillach; Jorge Joven; Domenico Girelli; Jordi Camps
Journal:  J Lipid Res       Date:  2013-03-06       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.